Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 5,000 | 0 | 0 | 5,000 | 0 |
| Gross Profit | 5,000 | N/A | N/A | 5,000 | N/A |
| Operating Expenses | 31,657 | 24,772 | 19,663 | 21,887 | 14,415 |
| Operating Income | -26,657 | -24,772 | -19,663 | -16,887 | -14,415 |
| Interest Expense | 281 | 320 | 365 | 400 | 436 |
| Other Income | 2,916 | 2,995 | 2,842 | 1,329 | 1,233 |
| Pre-tax Income | -24,022 | -22,097 | -17,186 | -15,958 | -13,618 |
| Income Tax | -60 | -19 | N/A | N/A | N/A |
| Net Income Continuous | -23,962 | -22,078 | -16,994 | -15,958 | -13,618 |
| Net Income | $-23,962 | $-22,078 | $-16,994 | $-15,958 | $-13,618 |
| EPS Basic Total Ops | -0.89 | -0.82 | -0.64 | -0.66 | -0.57 |
| EPS Basic Continuous Ops | -0.89 | -0.82 | -0.64 | -0.66 | -0.57 |
| EPS Diluted Total Ops | -0.89 | -0.82 | -0.64 | -0.66 | -0.57 |
| EPS Diluted Continuous Ops | -0.89 | -0.82 | -0.64 | -0.66 | -0.57 |
| EBITDA(a) | $-26,533 | $-24,657 | $-20,790 | $-16,796 | $-14,351 |